Skip to content
Saturday 29 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Thursday 23 July 2015 4:42 am

There could be a pill that stops gluten intolerance in just three years

By: Sarah Spickernell

Add as a preferred source on Google

For years, gluten intolerance has stopped millions of people enjoying some of the most delicious foods around, but scientists at the University of Alberta in Canada think they've found a way to treat the disorder.
 
Read more: Sainsbury's, Waitrose and Asda recall “gluten free” products over fears they contain gluten
 
They have created a natural supplement pill, based on yolks from chicken eggs, that stops sufferers absorbing gliadin – the component of gluten they have difficulty digesting. Normally, the gliadin damages the absorptive surface of the small intestine. 
 
“This supplement binds with gluten in the stomach and help to neutralize it, therefore providing defence to the small intestine, limiting the damage gliadin causes,” explained Hoon Sunwoo, a lead researcher in the study.  
 
“It is our hope that this supplement will improve the quality of life for those who have coeliac disease and gluten intolerance.”
 
Symptoms of gluten intolerance, also known as coeliac disease, include anaemia, headaches, bloating and fatigue. It affects around one in every 100 people in the UK, and means they can't indulge in foods like bread, pizza and pasta. They also can't drink beer, which is known to be Britain's favourite drink. 

Coming to a pharmacy near you

The next step for Sunwoo and his team of researchers is to put the pill through an efficacy trial, which they hope will get under way within the next year. 
 
They have teamed up with IGY and Vetanda Group through an agreement with TEC Edmonton to bring the supplement to market if the results are positive. 
 
If all goes according to plan, it could be made available in three years time, and not just in Canada, but around the world. 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • As it happened: FTSE 100 falls but Nasdaq soars after Nvidia sales boom

More from Morning Wire

  • ‘Cheers to Beer’ Celebrates the Drink at the Heart of Life’s Meaningful Moments

    Business Wire
  • Jobs market ‘stops moving’ as employment costs weigh on hirers

    Economics
    The recruitment industry is grappling with a slowdown in hiring among UK employers and wider macro-economic uncertainty.
  • How patient can the Bank of England be?

    AD
    Historic Royal Exchange building in London with modern skyscrapers behind, clear blue sky.
  • Are cars really the problem? London cyclists, it’s time to look within our ranks

    Opinion
    London cyclists ride Lime bikes and personal bicycles on a city street, promoting urban mobility and eco-friendly transport.
  • UK founders cast doubt on Burnham’s pro-business push

    Entrepreneurship
    Andy Burnham, Mayor of Greater Manchester, in a professional setting.
  • Freenow by Lyft is enhancing the taxi experience with unique tech innovations

    Partner
    Hand holding a smartphone displaying the FreeNow by Lyft app, with a smiling driver in a car background
  • The Expensify Visa® Commercial Card Brings New Proactive Spend Controls to 14 Countries

    Business Wire
  • Hammersmith Bridge is a test for Burnham’s place-based growth

    Opinion
    Hammersmith Bridge closed in 2021 with fencing, banners, and traffic cones blocking access to the walkway.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook